Opioid plaintiffs fight bid to disqualify U.S. judge before trial

By Nate Raymond (Reuters) - Lawyers for cities and counties suing drug companies over the opioid epidemic on Monday objected to a bid by pharmaceutical distributors and pharmacies to disqualify the federal judge overseeing the cases, saying it had no basis and came too late. The plaintiffs' lawyers moved swiftly to fight the request companies including AmerisourceBergen Corp , Cardinal Health Inc and McKesson Corp had made on Saturday for U.S.

Reuters September 17, 2019 02:06:06 IST
Opioid plaintiffs fight bid to disqualify U.S. judge before trial

Opioid plaintiffs fight bid to disqualify US judge before trial

By Nate Raymond

(Reuters) - Lawyers for cities and counties suing drug companies over the opioid epidemic on Monday objected to a bid by pharmaceutical distributors and pharmacies to disqualify the federal judge overseeing the cases, saying it had no basis and came too late.

The plaintiffs' lawyers moved swiftly to fight the request companies including AmerisourceBergen Corp , Cardinal Health Inc and McKesson Corp had made on Saturday for U.S. District Judge Dan Polster in Cleveland, Ohio, to step aside from the litigation.

In Monday's brief, lawyers for the plaintiffs said the defendants had waived their ability to seek Polster's recusal, noting they were relying on statements he made more than a year ago to belatedly seek his disqualification.

"If these Defendants really thought recusal was necessary, they were required to raise the issue sooner - much sooner," the plaintiffs' lawyers wrote.

More than 2,500 lawsuits by state and local governments are pending nationally, accusing drug manufacturers of deceptively marketing opioids in ways that downplayed their risks, and drug distributors of failing to detect and halt suspicious orders.

The companies deny wrongdoing. Nearly 2,100 of the lawsuits are before Polster, while others are in state courts.

The companies had argued in Saturday's motion that Polster, who has long pushed for a settlement that could "do something meaningful to abate this crisis," had made a series of public statements since 2018 that could cause a reasonable person to question his impartiality.

They said those statements, made in court hearings and media interviews, raised the prospect that he had improperly prejudged their liability ahead of the first trial on Oct. 21 involving two Ohio counties seeking $8 billion.

In Monday's brief, the plaintiffs' lawyers said the companies did not take action when Polster made those comments and actively participated in court-overseen settlement talks without objection.

Polster "has at no time expressed improper or biased views about the liability of any defendant, much less views based on extra-judicial sources," the lawyers wrote.

The companies who joined Saturday's motion also include CVS Health Corp and Walmart Inc . The defendants did not respond to requests for comment.

Opioids were involved in 400,000 overdose deaths from 1999 to 2017, according to the U.S. Centers for Disease Control and Prevention.

OxyContin maker Purdue Pharma, one of the lead defendants, filed for bankruptcy protection on Monday after reaching a tentative deal to resolve claims in the federal litigation and by 24 U.S. states.

(Reporting by Nate Raymond in Boston; Editing by Bill Berkrot)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Aurora Cannabis plans more layoffs, facility closures amid industry turmoil
Business

Aurora Cannabis plans more layoffs, facility closures amid industry turmoil

By Arunima Kumar (Reuters) - Aurora Cannabis on Tuesday announced a new round of staff reductions and plans to shut five facilities over the next two quarters, as the COVID-19 pandemic pummels the cash-crunched cannabis industry. For most marijuana companies in Canada, which legalized recreational cannabis in October 2018, profits have proven elusive due to fewer-than-expected retail stores, cheaper rates on the black market and slow overseas growth. The industry has been further hit by the COVID-19 crisis, which has also upended financial markets, making it harder to get investor dollars

India levies charge on some steel imports from China, Korea, Vietnam
Business

India levies charge on some steel imports from China, Korea, Vietnam

NEW DELHI (Reuters) - India has imposed an anti-dumping duty on flat rolled steel products that are plated or coated with alloy of aluminium and zinc originating in, or from China, Vietnam and South Korea, according to a government order https://www.cbic.gov.in/resources//htdocs-cbec/customs/cs-act/notifications/notfns-2020/cs-add2020/csadd16-2020.pdf issued on Tuesday. The duty will be in the range of $13.07-$173.10 per tonne for 5 years, according to the statement

Gold vaults to highest since October 2012 as dollar stumbles
Business

Gold vaults to highest since October 2012 as dollar stumbles

By Diptendu Lahiri (Reuters) - Gold prices surged to their highest since October 2012 on Tuesday, driven by a weakness in the U.S. dollar and widespread monetary stimulus packages by central banks as a jump in coronavirus cases dents the economic outlook